At the Academic Council meeting, President Marc Tessier-Lavigne discussed how Stanford is pivoting its Long-Range Vision in light of COVID-19, and announced Stanford is designing a school focused on climate and sustainability.
Plans for Stanford’s new Innovative Medicines Accelerator arose before the COVID-19 pandemic struck, but now its programs are focused entirely on helping faculty generate and test new medicines to slow the spread of the disease.
Global carbon dioxide emissions are down dramatically in the wake of COVID-19. A new study pinpoints where energy demand has dropped the most, estimates the impact on annual emissions and points the way to a less polluted future.
The inability of 14th-century medicine to stop the plague from destroying societies throughout Europe and Asia helped advance scientific discovery and transformed politics and health policy, says Stanford historian Paula Findlen.
Scientists at Stanford Medicine are investigating whether a molecule called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce their transmission of the disease-causing virus.